Nov. 6, 2007 — Researchers at the University of Virginia Health System have identified an enzyme thought to be an important instigator of the inner-body conflict causes Type 1 diabetes. A chronic condition that affects nearly 3 million American children and adults, Type 1 diabetes is more severe than Type 2. Type 1 diabetes, also called autoimmune diabetes, arises when the body's infection-fighting white blood cells start destroying the beta-cells that produce insulin in the pancreas.
To shed light on how this conflict begins, U.Va. researchers focused on a single gene, 12/15-lipoxygenase (12/15-LO). This gene leads to the production of the enzyme, which appears to have an important role in the activation of white blood cells in the pancreas.
Researchers developed non-obese diabetic female mice to serve as a model of Type 1 diabetes. After turning off the 12/15-LO gene in study mice, they found that these mice without the enzyme were 97 percent less likely to develop diabetes than mice that had normal levels of it, according to the study, published online in the journal Diabetes (to be published in print in February).
"This research is exciting because it advances our knowledge of a new gene that is involved in causing Type 1 diabetes and could pave the way for new treatments to prevent or reverse this increasingly prevalent disease," said Dr. Jerry L. Nadler, chief of the U.Va. Division of Endocrinology and Metabolism.
U.Va. researchers also discovered that study mice that did not have the 12/15-LO gene and remained non-diabetic demonstrated better glucose tolerance than non-diabetic mice that were matched for age. (Worse glucose tolerance is an indication of having a pre-diabetes condition). The same group of study mice also had improved beta cell mass and less severe insulitis than their non-diabetic counterparts.
Insulitis is a change in the islet cells that includes a high-fluid volume and too many white blood cells. While white blood cells normally help to fight off infections, they can cause damage over time when they infiltrate the islet cells of the pancreas.
"Our findings have two practical implications," said co-author Marcia McDuffie, professor of microbiology at U.Va. "First, they help us to understand the complicated process that produces self-destructive white blood cells. This knowledge may be useful in predicting which children may be at risk for developing Type 1 diabetes before significant damage has occurred in the islets. Second, we may be able to design drugs targeting this enzyme that may help to prevent Type 1 diabetes in people at risk for the disease and also to prevent recurrence of disease in transplanted islets."
Type 1 diabetes requires insulin injections, because the body cannot produce insulin on its own.
| Photos at right: Pancreatic sections displaying insulin-producing beta cells within islets (dark purple). Fourteen non-diabetic mice without the gene for 12/15-lipoxygenase and 10 non-diabetic mice with the gene were evaluated for beta-cell degradation. Top, a representative example of a well-preserved islet in a non-diabetic mouse without the gene for the enzyme. Bottom. a representative example of an infiltrated islet damaged by white blood cells from an age-matched non-diabetic mouse that does produce the enzyme. |
Researchers developed non-obese diabetic female mice to serve as a model of Type 1 diabetes. After turning off the 12/15-LO gene in study mice, they found that these mice without the enzyme were 97 percent less likely to develop diabetes than mice that had normal levels of it, according to the study, published online in the journal Diabetes (to be published in print in February).
"This research is exciting because it advances our knowledge of a new gene that is involved in causing Type 1 diabetes and could pave the way for new treatments to prevent or reverse this increasingly prevalent disease," said Dr. Jerry L. Nadler, chief of the U.Va. Division of Endocrinology and Metabolism.
U.Va. researchers also discovered that study mice that did not have the 12/15-LO gene and remained non-diabetic demonstrated better glucose tolerance than non-diabetic mice that were matched for age. (Worse glucose tolerance is an indication of having a pre-diabetes condition). The same group of study mice also had improved beta cell mass and less severe insulitis than their non-diabetic counterparts.
Insulitis is a change in the islet cells that includes a high-fluid volume and too many white blood cells. While white blood cells normally help to fight off infections, they can cause damage over time when they infiltrate the islet cells of the pancreas.
"Our findings have two practical implications," said co-author Marcia McDuffie, professor of microbiology at U.Va. "First, they help us to understand the complicated process that produces self-destructive white blood cells. This knowledge may be useful in predicting which children may be at risk for developing Type 1 diabetes before significant damage has occurred in the islets. Second, we may be able to design drugs targeting this enzyme that may help to prevent Type 1 diabetes in people at risk for the disease and also to prevent recurrence of disease in transplanted islets."
Type 1 diabetes requires insulin injections, because the body cannot produce insulin on its own.
Media Contact
Article Information
November 6, 2007
/content/uva-health-system-team-uncovers-genes-role-type-1-diabetes